“I think it is a moral requirement to make money when you can . . . to sell the product for the highest price.”
“The point here is the only other choice is the brand at the higher price. It is still a saving regardless of whether it is a big one or not,”
“I agree with Martin Shkreli that when he raised the price of his drug he was within his rights because he had to reward his shareholders,”
“If he’s the only one selling it then he can make as much money as he can,”
“This is a capitalist economy and if you can’t make money you can’t stay in business.”
said Nirmal Mulye. Nostrum chief executive, in an interview…
read Pharma chief defends 400% drug price rise as a ‘moral requirement’ in the Financial Times September 11, 2018